Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

2 leading ASX growth shares I’d buy this month

I'm always on the lookout for interesting ASX growth shares that may be able to achieve good returns over the long-term.

I’m always on the lookout for interesting ASX growth shares that may be able to achieve good returns over the long-term.

Businesses that can achieve good compound growth can become much larger over the long-term, which hopefully translates into profit and shareholders returns.

I believe these two ideas offer plenty of potential for investors:

Volpara Health Technologies Ltd (ASX: VHT)

This business is a leader in the healthcare space. It provides breast screening technology, risk analysis and practice management.

The company has been working on being able to offer patients personalised breast care and enhanced risk assessment.

It has reached a market share of 35.5% of women in the US who have a company product applied on their images and data. It has a gross profit margin of 91% and total revenue in FY22 jumped 32% to NZ$26.1 million in FY22.

I like that the company is now focused on reaching operating cashflow breakeven and it’s chasing the large, high-value sales, while reducing costs.

In the long-term, I’m excited by the potential for Volpara to grow its presence in non-US countries like Europe. It’s also involved with lung cancer screening, which I think could be a future long-term expansion market.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

This is one of my favourite exchange-traded funds (ETFs) because it combines the dynamic investing of active stock picking with passive-like low costs.

It has an annual management fee of 0.49%. To 31 July 2022, the MOAT ETF has produced an average return per annum of 16.4% over the prior five years. Who knows what the next five years will be like? But, I think it can keep delivering good outperformance.

The tactics of the investment team behind this ETF is that it’s trying to invest in a “diversified portfolio of attractively priced US companies with sustainable competitive advantages according to Morningstar’s equity research team.”

The idea is that the durability of economic profits is far more important than how big the profits are. Clear evidence must exist that the company benefits from one of five moat sources: intangible assets, cost advantage, switching costs, network effects and efficient scale.

Targets companies must be trading at attractive prices relative to Morningstar’s estimate of fair value.

Some of the current investments include: KelloggGilead SciencesPolarisEcolabEtsyBlackrockBoeingBiogenAmazon.com and Tyler Technologies. But, the holdings regularly change.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content